AvKARE Valsartan and Hydrochlorothiazide Tablets Recalled for Carcinogen Impurity
AvKARE is recalling specific lots of Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
- Product
- AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-887-90
- Category
- Drug
- Distribution
- Distributed nationwide